Lenomorelin

DB11895InvestigationalProtein Based Therapies

Lenomorelin has been investigated for the treatment and basic science of Cancer, Alcoholism, Metabolism, Hypopituitarism, and Frailty Syndrome, among others.

Mechanism: Pharmacologically active on Growth hormone secretagogue receptor type 1
Curator reviewed
Also known as: Ghrelin · Ghrelin (human) · Ghrelin human · Human ghrelin

Resolves to

Compound

UNIIUXG268Q86RCAS258279-04-8

Targets

Q92847GHSR

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

33Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Lenomorelin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account